Susan Holbeck

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers13 papers

Sort

By YearBy Citation

Predicting tumor cell line response to drug pairs with deep learning

Fangfang Xia,Maulik Shukla, Thomas Brettin,Cristina Garcia-Cardona,Judith Cohn,Jonathan E Allen,Sergei Maslov,Susan L Holbeck,James H Doroshow, Yvonne A Evrard, Eric A Stahlberg,Rick L Stevens

BMC Bioinformatics, no. Suppl 18 (2018): 486

Cited by17WOSEIBibtex

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Susan Holbeck,Richard F. Camalier,James A. Crowell, Jeevan Prasaad Govindharajulu,Melinda G. Hollingshead,Lawrence W. Anderson, Eric C. Polley,Larry Rubinstein, Apurva K. Srivastava,Deborah Wilsker,Jerry M. Collins,James H. Doroshow

Cancer Research, no. 13 (2017): 3564-3576

Cited by14Bibtex

Abstract 845: A clinically validated multiplex immunofluorescence assay for the quantitative assessment of changes in EMT phenotypes in FFPE tumor tissues in response to cancer therapeutics

Tony Navas,Melinda G. Hollingshead,Suzanne Borgel, John Carter,Angelena Millione, Brad A. Gouker, Donna O. Butcher,Susan Holbeck, Apurva K. Srivastava,Robert J. Kinders,Donald P. Bottaro, Shivaani Kumar

Cancer Research, (2017): 845-845

Bibtex

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors

Geraldine Helen O'Sullivan Coyne,Shivaani Kummar,Khanh Do,Susan Holbeck,Melinda G. Hollingshead,Yvonne Horneffer,Lamin Juwara, Apurva K. Srivastava,Larry Rubinstein,Richard Piekarz,Elad Sharon,Howard Streicher

Journal of Clinical Oncology, (2017)

Bibtex

Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay

Jiuping Ji, Yiping Zhang,Christophe E Redon,William C Reinhold,Alice P Chen, Laura K Fogli,Susan L Holbeck, Ralph E Parchment,Melinda Hollingshead,Joseph E Tomaszewski, Quentin Dudon,Yves Pommier

PloS one, no. 2 (2017)

Cited by13WOSBibtex

Using gamma-H2AX and H2AX quantitative ELISA for monitoring DNA damage induced by chemotherapeutic agents and irradiation exposure

Jiuping Jay Ji,Yiping Zhang,Christophe E. Redon,Alice Chen,Susan Holbeck,Melinda G. Hollingshead,Ralph E. Parchment,Yves Pommier,Joseph E. Tomaszewski,James H. Doroshow,William M. Bonner

Journal of Clinical Oncology, (2017)

Bibtex

Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions

Susan Holbeck,Jianjun Chang, Anne M Best,Angie L Bookout,David J Mangelsdorf,Elisabeth D Martinez

Molecular endocrinology (Baltimore, Md.), no. 6 (2010): 1287-1296

Cited by37WOSBibtex

Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen

John F Deeken,Robert W Robey,Suneet Shukla,Kenneth Steadman,Arup R Chakraborty,Balasubramanian Poonkuzhali,Erin G Schuetz,Susan Holbeck,Suresh V Ambudkar,Susan E Bates

MOLECULAR PHARMACOLOGY, no. 5 (2009): 946-956

Cited by12WOSBibtex

Batracylin, 8-aminoisoindolo [1,2-b]quinazolin-10(12H)-one (NSC 320846), a dual inhibitor of DNA topoisomerases I and II: molecular mechanisms and γ-H2AX as a biomarker of DNA damage

V. Ashutosh Rao,Keli Agama,Susan Holbeck,Yves Pommier

MOLECULAR CANCER THERAPEUTICS, no. 12 (2007): 3392S-3393S

Bibtex

Bisindenoisoquinoline NSC 727357, a DNA intercalator and topoisomerase inhibitor with antitumor activity

Smitha Antony,Keli Agama,Ze-Hong Miao,Melinda G. Hollingshead,Susan Holbeck,Mollie H. Wright,Lyuba Varticovski,Muthukaman Nagarajan,Andrew Morrell,Mark Cushman,Yves Pommier

MOLECULAR PHARMACOLOGY, no. 3 (2006): 1109-1120

Bibtex

The US-NCI cell based screen The role of target expression profiling in developmental therapeutics

A. Monks,S. Holbeck,D. A. Scudiero,D. G. Covell,R. H. Shoemaker,E. A. Sausville

Onkologie, no. 4 (2003): 388-389

Bibtex

Natural Products and Derivatives as Leads to Cell Cycle Pathway Targets in Cancer Chemotherapy

D. J. Newman,G. M. Cragg,S. Holbeck,E. A. Sausville

CURRENT CANCER DRUG TARGETS, no. 4 (2002): 279-308

Cited by71WOSBibtex

Molecular analysis of DQβ3.1 genes

S HOLBECK,G NEPOM

Human Immunology, no. 3 (1988): 183-192

Cited by1Bibtex

View All

Base Info Papers Patents Projects

Susan HolbeckBinding

Papers13 papers

Susan Holbeck